Multiphoton imaging of the monosachharide induced formation of fluorescent advanced glycation end products in tissues

被引:1
|
作者
Lin, Chih-Ju [1 ]
Mondal, Sohidul [1 ]
Lee, Sheng-Lin [1 ]
Kang, Jeon-Woong [2 ]
So, Peter T. C. [2 ,3 ,4 ]
Dong, Chen Yuan [1 ,5 ]
机构
[1] Natl Taiwan Univ, Dept Phys, Taipei, Taiwan
[2] MIT, Laser Biomed Res Ctr, GR Harrison Spect Lab, Cambridge, MA 02139 USA
[3] MIT, Dept Mech Engn, Cambridge, MA USA
[4] MIT, Dept Biol Engn, Cambridge, MA USA
[5] Natl Taiwan Univ, Dept Phys, Taipei 10617, Taiwan
关键词
autofluorescence; fluorescent advanced glycation end products (fAGEs); multiphoton microscopy; second harmonic generation (SHG); tissue glycation; SKIN AUTOFLUORESCENCE; COMPLICATIONS; RISK; MICROSCOPY; REDUCTION; AGES;
D O I
10.1002/jbio.202300261
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We studied the in vitro rate of fluorescent advanced glycation end products (fAGEs) formation with multiphoton microscopy in different porcine tissues (aorta, cornea, kidney, dermis, and tendon). These tissues were treated with d-glucose, d-galactose, and d-fructose, three primary monosaccharides found in human diets. We found that the use of d-fructose resulted in the highest glycation rate, followed by d-galactose and then d-glucose. Moreover, compared to non-collagen tissue constituents such as elastic fibers and cells, the rate of tissue glycation was consistently higher in collagen, suggesting that collagen is a more sensitive target for fAGE formation. However, we also found that collagen in different tissues exhibits different rates of fAGE formation, with slower rates observed in tightly packed tissues such as cornea and tendon. Our study suggests that for fAGE to be developed into a long-term glycemic biomarker, loosely organized collagen tissues located in the proximity of vasculature may be the best targets. The rate of formation of fluorescent advanced glycation end products (fAGEs) in different glycated porcine tissues (aorta, cornea, kidney, dermis, and tendon) is measured by multiphoton microscopy. According to the measurement, the glycation rate in fructose is highest followed by galactose and glucose. Collagenous tissues glycate at a rate that is significantly greater than non-collagenous tissues. However, the rate of fAGE synthesis varies among collagen in various tissues. These findings may be of value in developing long-term glycemic biomarkers for diabetes.image
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Fluorescent advanced glycation end products in the detection of factual stages of cartilage degeneration
    Handl, M.
    Filova, E.
    Kubala, M.
    Lansky, Z.
    Kolacna, L.
    Vorlicek, J.
    Trc, T.
    Pach, M.
    Amler, E.
    PHYSIOLOGICAL RESEARCH, 2007, 56 (02) : 235 - 242
  • [32] Dietary quercetin inhibits methylglyoxal-induced advanced glycation end products formation in mice
    Zhao, Yantao
    Wang, Pei
    Chen, Huadong
    Sang, Shengmin
    FASEB JOURNAL, 2016, 30
  • [33] Glyoxal induced advanced glycation end products formation in chicken meat emulsion instead of oxidation
    Fang, Rui
    Zhu, Zongshuai
    Bassey, Anthony Pius
    Khan, Iftikhar Ali
    Huang, Ming
    FOOD SCIENCE AND HUMAN WELLNESS, 2022, 11 (04) : 828 - 836
  • [34] Glyoxal induced advanced glycation end products formation in chicken meat emulsion instead of oxidation
    Rui Fang
    Zongshuai Zhu
    Anthony Pius Bassey
    Iftikhar Ali Khan
    Ming Huang
    FoodScienceandHumanWellness, 2022, 11 (04) : 828 - 836
  • [35] Advanced glycation end products and the kidney
    Bohlender, JM
    Franke, S
    Stein, G
    Wolf, G
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (04) : F645 - F659
  • [36] Structures Required of Polyphenols for Inhibiting Advanced Glycation end Products Formation
    Xie, Yixi
    Chen, Xiaoqing
    CURRENT DRUG METABOLISM, 2013, 14 (04) : 414 - 431
  • [37] Benfotiamine inhibits intracellular formation of advanced glycation end products in vivo
    Lin, JH
    Alt, A
    Liersch, J
    Bretzel, RG
    Brownlee, MA
    Hammes, HP
    DIABETES, 2000, 49 : A143 - A143
  • [38] Advanced glycation end products in uremia
    Henle, T
    Miyata, T
    ADVANCES IN RENAL REPLACEMENT THERAPY, 2003, 10 (04): : 321 - 331
  • [39] Role of Advanced Glycation End Products in Neutrophil Extracellular Trap Formation
    Cooney, Riley
    Ahmadi, Layla
    Petreaca, Melissa
    FASEB JOURNAL, 2019, 33
  • [40] Advanced Glycation End Products and Psoriasis
    Maurelli, Martina
    Gisondi, Paolo
    Girolomoni, Giampiero
    VACCINES, 2023, 11 (03)